TABLE 1.

Correlation between CASZ1 expression and clinicopathological characteristics of primary glioma patient (n = 422)

	CASZ1 expression
Characteristics	Low expression	High expression	p‐Value
Age
≥40	126	137	0.242
<40	85	73
NA	0	1
Gender
Male	120	123	0.768
Female	91	88
WHO grade
WHO II	82	56	<0.001
WHO III	80	64
WHO IV	49	91
Histopathology
O	17	6	<0.001
OA	46	31
A	19	19
AO	23	5
AOA	43	39
AA	14	20
GBM	49	91
IDH
Mutation	109	99	0.037
Wildtype	73	102
NA	29	10
1p/19q
Codel	64	24	<0.001
Non‐codel	110	164
NA	37	23
Radiotherapy
Yes	150	163	0.224
No	49	38
NA	12	10
Chemotherapy
Yes	141	140	0.825
No	54	61
NA	16	10

Abbreviations: A, astrocytoma; AA, anaplastic astrocytoma; AO, anaplastic oligodendroglioma; AOA, anaplastic oligoastrocytoma; GBM, glioblastoma; NA, not available; O, oligodendroglioma; OA, oligoastrocytoma.